Vasculitis & polymyalgia rheumatica

Distinct clinical outcomes of positron emission tomography/computed tomography-based subtypes in treatment-naïve Takayasu arteritis

Scand J RheumatolPublished Retrospective cohort study

Authors' conclusion

PET/CT-based classification suggested three distinct TAK subtypes with different clinical outcomes. The diffuse type was significantly associated with relapse, whereas the thoracic type caused vascular complications.

Study context

Population
Patients with treatment-naïve TAK who underwent PET/CT before treatment initiation (90% women; median age at diagnosis 48 years)median follow-up 4.8 years
Participants
30 patients
Exposure
PET/CT-based clusters: thoracic vs diffuse vs localized
Outcome
Clinical outcomes, including relapse and large-vessel complications, by PET/CT-based cluster
Methodological detailshierarchical clustering, survival analyses
  • Hierarchical clustering
  • Survival analyses

Main finding

As reported in the abstract

Relapse rate

Diffuse

24.1

/100 person-years

Diffuse type showed the highest relapse rate
P = 0.04

Observational data: associations, not effects.

Further findings

Vascular complications — Thoracic
13.9 /100 person-years
Vascular complications — Thoracic type tended to be associated with more vascular complications
p = 0.12

Numano classification

Did not always correspond to PET/CT-based clusters or predict clinical outcomes

PET Vascular Activity Score ≥ 7

Associated with relapse but not with vascular complications

Longitudinal PET/CT activity

PET/CT activity persisted despite clinical inactivity in some cases

Original publication

Distinct clinical outcomes of positron emission tomography/computed tomography-based subtypes in treatment-naïve Takayasu arteritis. Scand J Rheumatol. Published 3 July 2026. doi:10.1080/03009742.2026.2677340

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.